These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2093422)

  • 41. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
    Devissaguet M
    Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus.
    Villa RF; Ghigini B; Arnaboldi R; Geroldi D; Gorini A
    Eur J Basic Appl Histochem; 1991; 35(4):409-21. PubMed ID: 1801934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
    Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
    Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
    Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
    Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
    Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
    Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The predictive parameters in the response to almitrine treatment].
    González Ruiz JM; Villamor J; Pino JM; Muñoz J; Lobato SD; Prados C
    Arch Bronconeumol; 1994 Mar; 30(3):141-4. PubMed ID: 8186906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Almitrine bismesylate treatment in chronic respiratory insufficiency].
    González Ruiz JM; Villamor León J; García-Satué JL; Sánchez Agudo L; Calatrava JM; Carreras J
    Rev Clin Esp; 1994 Dec; 194(12):1007-12. PubMed ID: 7863045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
    Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
    Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The influence of aging on cerebral energy metabolism following post-hypoglycemic recovery in the rat. Pharmacologic application].
    Villa RF; Pastoris O
    J Pharmacol; 1986; 17(4):623-36. PubMed ID: 3560973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypoxemia during one-lung ventilation using intravenous almitrine.
    Dalibon N; Moutafis M; Liu N; Law-Koune JD; Monsel S; Fischler M
    Anesth Analg; 2004 Mar; 98(3):590-4, table of contents. PubMed ID: 14980903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
    Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE
    Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
    Balestreri R; Fontana L; Astengo F
    J Am Geriatr Soc; 1987 May; 35(5):425-30. PubMed ID: 3553281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation.
    Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A
    Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
    Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
    Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP; Di Sciascio G; Durbano F; Mencacci C; Rubiera M; Aguglia E; Garavini A; Bersani G; Di Sotto A; Placidi G; Cesana BM
    Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
    Schütz RM; Teufel W; Glocke M
    Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life.
    Predescu V; Riga D; Riga S; Turlea J; Bărbat IM; Botezat-Antonescu L
    Ann N Y Acad Sci; 1994 Jun; 717():315-31. PubMed ID: 8030848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
    Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
    Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral neuropathy in patients treated with almitrine dimesylate.
    Gherardi R; Louarn F; Benvenuti C; Perrier M; Lejonc JL; Schaeffer A; Degos JD
    Lancet; 1985 Jun; 1(8440):1247-50. PubMed ID: 2860446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.